You are here

Mary C. Tierney, MS
Vice President & Chief Content Officer, TriMed Media Group
Mary joined TriMed Media in 2003. She was the founding editor and editorial director of Health Imaging, Cardiovascular Business, Molecular Imaging Insight and CMIO, now known as Clinical Innovation + Technology. Prior to TriMed, Mary was the editorial director of HealthTech Publishing Company, where she had worked since 1991. While there, she oversaw four magazines and related online media, and piloted the launch of two magazines and websites. Mary holds a master’s in journalism from Syracuse University. She lives in East Greenwich, R.I., and when not working, she is usually running around after her family, taking photos or cooking.
 - Memorial Hospital

Delivering key images, reports and patient data to the point of diagnosis and care is the Holy Grail of radiology and many other specialties today. Having the correct information for the patient at the right time for the radiologist or referring physician starts with having the right viewer.

Texas-based Baylor College of Medicine and California-based Radiology Partners, a physician-operated radiology practice, are partnering to provide services to Baylor’s academic hospital, Baylor St. Luke’s Medical Center, Catholic Health Initiatives network hospitals and other community hospitals in the Greater Houston area and Southeast Texas.

 - EarlyMammography

According to a new survey, a majority of U.S. women remain unaware of overdiagnosis and overtreatment, two of the biggest risks associated with breast cancer screenings.

 - time, calendar, delay

Breast MRI is often used to evaluate newly diagnosed breast cancers, but there is some evidence that suggests this practice can lead to delayed surgical treatment. To explore that issue more closely, the authors of a recent study in the Journal of the American College of Radiology carried out a retrospective study of 189 patients who were diagnosed and treated for breast cancer at the same facility.

 - DocScan

When we look at the future of PET, we think of new biomarkers and applications. Is conventional FDG PET maxed out? Or is there room to improve now? No it is not, and yes there is, molecular imaging experts say.